Keeping Current

521 Episodo

1. Time to Reassess Biomarkers in Multiple Myeloma?

   Publicado: 3/6/2020
2. COVID-19 Pandemic: Further Implications for Diabetes Care

   Publicado: 2/6/2020
3. Early Intervention in COPD: Are 2 Bronchodilators Better Than 1?

   Publicado: 1/6/2020
4. COVID-19 and Mental Health: Taking Positive Action in This New Environment

   Publicado: 26/5/2020
5. COVID-19 and Comorbidities: Unhappy Bedfellows

   Publicado: 11/5/2020
6. COVID-19 Pandemic: The Implications for Diabetes Care

   Publicado: 6/5/2020
7. The Evolution of Knowledge on COVID-19 and Multiple Sclerosis

   Publicado: 4/5/2020
8. Moving Towards Routine Use of Comprehensive Genomic Profiling Across Oncology: From Clinical Rationale to Practical Application

   Publicado: 1/5/2020
9. What You Need to Know About CAR T-Cell Therapy in Multiple Myeloma: A Deep Dive

   Publicado: 27/4/2020
10. What You Need to Know About CAR T-Cell Therapy in NHL: A Deep Dive

    Publicado: 24/4/2020
11. What We Currently Know About COVID-19 and MS

    Publicado: 17/4/2020
12. The AxSpA Spectrum of Diseases: How to Diagnose and Manage Patients in Clinical Practice?

    Publicado: 31/3/2020
13. Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment

    Publicado: 31/3/2020
14. COPD: Patient Selection Based on GOLD Guidance and Response to Therapy

    Publicado: 31/3/2020
15. CAR T-Cell Therapy in Non-Hodgkin Lymphoma and Multiple Myeloma: A Clinical Update

    Publicado: 21/3/2020
16. Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice

    Publicado: 26/12/2019
17. Idiopathic Pulmonary Fibrosis: The Right Treatments at the Right Time

    Publicado: 14/12/2019
18. Approaching a New Era in the Management of Progressive Fibrosing ILDs

    Publicado: 15/11/2019
19. How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease?

    Publicado: 19/9/2019
20. Working Together to Diagnose Idiopathic Pulmonary Fibrosis

    Publicado: 20/8/2019